Skip to main content
. 2020 Oct 28;4(4):e309–e317. doi: 10.1055/s-0040-1718883

Fig. 3.

Fig. 3

Cumulative incidence of subsequent bleeding, adjusted for the competing risk of subsequent VTE and death, among treated California acute leukemia patients with an upper extremity deep vein thrombosis, 2009 to 2014. AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; VTE, venous thromboembolism.